British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness live – latest updatesGSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two-lat
This summary is provided by Daily Junction. The original article is published by The Guardian and all rights remain with the original publisher.
Expanding between the UK and Australia is easier than most international moves — but shared language masks real differences in…
A unique selling point is the one thing that makes your business the obvious choice over rivals. This guide explains what a USP…
Most businesses pour money into winning customers and neglect keeping them. Here is why retention usually beats acquisition, how…
Enjoying Daily Junction?
Get our best stories delivered free every morning.
Before you go…
Join 11,400+ readers who get the day's most important stories, clearly explained — free every morning.
